HOME › DRUGS › VORASIDENIB
ACTIVE SUBSTANCE / INN

VORASIDENIB

Brand name(s): Voranigo, VORANIGO
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
NDA218784
Oligodendroglioma;Astrocytoma
ACTIVE SUBSTANCE
Vorasidenib
REGULATORS
FDA · EMA
SPONSORS / MAH
SERVIER, Les Laboratoires Servier
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
VORANIGONDA218784SERVIERPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
VoranigoLes Laboratoires ServierAuthorised17/09/2025Oligodendroglioma;Astrocytoma

FULL INTELLIGENCE ON VORASIDENIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →